Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis
Archives of Medical Science (2013) - Comments
pubmed: 24273556  doi: 10.5114/aoms.2013.38670  issn: 1734-1922 

Paweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, Andrzej Pilc